文献速递母胎医学产科

产前代谢组学分析与胎儿先天畸形及遗传状况:当前文献综述

Prenatal Metabolomics Analysis and Fetal Congenital Anomalies and Genetic Conditions: A Review of Current Literature.
PubMed 文献 · Prenat Diagn · 2025-09-19

胎儿先天畸形和遗传疾病占妊娠的3%-5%,精准的产前诊断对咨询和管理至关重要。代谢组学作为功能检测手段,有望加深对产前先天畸形相关病理过程和遗传发现的理解。本文检索MEDLINE、Embase、Web of Science和Cochrane Library截至2025年3月的文献,聚焦于胎儿结构畸形或遗传疾病妊娠的代谢组学分析;代谢组学在产前筛查和诊断中有前景,但融入临床实践仍有限。

要点

  • 胎儿先天畸形和遗传疾病占妊娠的3%-5%,影响妊娠结局。
  • 代谢组学可作为功能检测,辅助解读全基因组测序发现的罕见遗传变异。
  • 代谢组学在产前筛查和诊断中有前景,但临床整合仍有限。

核心结论

  • 代谢组学是产前筛查和诊断中有前景的工具,但其融入临床实践仍有限。

研究设计与样本

  • 综合文献综述,检索MEDLINE(OVID)、Embase(Elsevier)、Web of Science(Clarivate)和Cochrane Library(Wiley)截至2025年3月的相关研究。
  • 聚焦于受胎儿结构畸形或遗传疾病影响的妊娠的代谢组学分析。

主要发现

  • 胎儿先天畸形和遗传疾病占妊娠的3%-5%,可对妊娠结局产生显著影响。
  • 代谢组学已成为解读全基因组测序所识别的罕见遗传状况的潜在辅助手段。
  • 代谢组学作为功能检测,有望更深入地揭示产前先天畸形相关的病理过程和遗传发现。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fetal congenital anomalies and genetic disorders complicate 3%-5% of pregnancies and can have a significant impact on pregnancy outcomes. Precise and individualized prenatal diagnosis is crucial for effective counseling and management. The identification of new biomarkers holds promise for enhancing prenatal screening, diagnosis, and prognostic counseling in affected pregnancies. Recently, metabolomics has emerged as a potential adjunct in the interpretation of genetic variants identified through genome-wide sequencing for rare genetic conditions. To assess the potential of metabolomic profiling as a functional assay capable of providing deeper insights into the pathological processes and genetic findings associated with prenatal congenital anomalies, we conducted a comprehensive literature review. We searched MEDLINE (OVID), Embase (Elsevier), Web of Science (Clarivate), and Cochrane Library (Wiley) for relevant studies published through March 2025, focusing on metabolomic profiling of pregnancies affected by fetal structural anomalies or genetic disorders. While metabolomics is a promising tool in prenatal screening and diagnosis, its integration into clinical practice remains limited.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Araji S, Turkoglu O, Maktabi MA, et al. Prenatal Metabolomics Analysis and Fetal Congenital Anomalies and Genetic Conditions: A Review of Current Literature. Prenat Diagn. 2025. PMID: 40973925. doi:10.1002/pd.6895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。